BMS-695735 T30538
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BMS-695735, a benzimidazole inhibitor of insulin-like growth factor-1 receptor, has broad-spectrum antitumor activity in vivo. It was found that BMS-695735 had strong inhibition of CYP3A4, induction of CYP3A4 mediated by PXR transactivation, poor water so
CAS nr:
1054315-48-8
Purity:
98%
Molecular Weight:
512,02
SMILES:
Cc1cc(cc2c1[nH]c(n2)c3c(cc[nH]c3=O)NCCn4cc(cn4)Cl)C5CCN(CC5)CCCF
Formula:
C26H31ClFN7O
Pathway:
Target:
